I'd agree with Ted on that latter recommendation.
I'd also like to see this opportunity taken to create a comprehensive strategy. We're funded by the Public Health Agency of Canada, and I'm dealing all the time with the mindset of public health physicians and researchers, which is that vaccines are the only answer. The world has changed. It's very clear, as I pointed out in my presentation, that antivirals have been the only tool we've had to use to combat HIV in the last 20 years, so a comprehensive approach... I understand that there are research programs that are supported through CIHR, but we're not talking about that; we're talking about translational research, we're talking about actually getting discoveries into a production mode, such that you can have GMP material to administer to patients in a clinical trial. That is not funded through CIHR. That needs a special mechanism, whether it's a drug or a vaccine candidate.